Cancer BiologybioRxivPreprint
CDH3 as a Novel Therapeutic Target in Basal-like Double-Negative Prostate Cancer
Guoqiang Liu, Shiyu Wang, Loan Duong…·Xin Lü
This study identifies CDH3 as a key driver of basal-like prostate cancer and shows that CDH3-targeted therapies like ADCs and CAR T cells are effective in preclinical models.
DOI 10.1101/2025.11.18.689150